4.6 Article

Frailty and Fracture, Disability, and Falls: A Multiple Country Study From the Global Longitudinal Study of Osteoporosis in Women

Journal

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Volume 61, Issue 3, Pages 327-334

Publisher

WILEY
DOI: 10.1111/jgs.12146

Keywords

falls; fracture; frailty; osteoporosis; postmenopausal; women

Funding

  1. Warner Chilcott Co, LLC
  2. Sanofi-Aventis
  3. Fund for Scientific Research, Flanders, Belgium (FWO-Vlaanderen)
  4. Eunice Kennedy Shriver National Institute of Child Health and Human Development
  5. Office of Research on Women's Health
  6. National Institute of Allergy & Infectious Diseases
  7. French Ministry of Health
  8. Merck
  9. Servier
  10. Lilly
  11. Procter
  12. Gamble
  13. Acuitas
  14. Nycomed
  15. AMGEN
  16. Alliance for Better Bone Health (sanofi-aventis)
  17. Alliance for Better Bone Health (Warner Chilcott)
  18. Eli Lily
  19. Merck Sharp
  20. Dohme
  21. Novartis
  22. Roche-GSK
  23. Alliance for Better Bone Health (Proctor Gamble)
  24. Kyphon
  25. Roche
  26. Alliance
  27. Merck Sharp and Dohme
  28. GlaxoSmithKline
  29. Wyeth
  30. [T32AG027677]
  31. [K12HD052023]
  32. MRC [MC_U147585819, G0400491, MC_U147585827] Funding Source: UKRI
  33. Medical Research Council [U1475000001, MC_U147585819, G0400491, MC_UU_12011/1, MC_UP_A620_1014, MC_U147585827, MC_U147585824] Funding Source: researchfish
  34. National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish

Ask authors/readers for more resources

Objectives To test whether women aged 55 and older with increasing evidence of a frailty phenotype would have greater risk of fractures, disability, and recurrent falls than women who were not frail, across geographic areas (Australia, Europe, and North America) and age groups. Design Multinational, longitudinal, observational cohort study. Setting Global Longitudinal Study of Osteoporosis in Women (GLOW). Participants Women (N=48,636) aged 55 and older enrolled at sites in Australia, Europe, and North America. Measurements Components of frailty (slowness and weakness, poor endurance and exhaustion, physical activity, and unintentional weight loss) at baseline and report of fracture, disability, and recurrent falls at 1year of follow-up were investigated. Women also reported health and demographic characteristics at baseline. Results Women younger than 75 from the United States were more likely to be prefrail and frail than those from Australia, Canada, and Europe. The distribution of frailty was similar according to region for women aged 75 and older. Odds ratios from multivariable models for frailty versus nonfrailty were 1.23 (95% confidence interval (CI)=1.071.42) for fracture, 2.29 (95% CI=2.092.51) for disability, and 1.68 (95% CI=1.541.83) for recurrent falls. The associations for prefrailty versus nonfrailty were weaker but still indicated statistically significantly greater risk of each outcome. Overall, associations between frailty and each outcome were similar across age and geographic region. Conclusion Greater evidence of a frailty phenotype is associated with greater risk of fracture, disability, and falls in women aged 55 and older in 10 countries, with similar patterns across age and geographic region.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available